1 / 8

Migraine Drugs Market Expected to boost $2,190 Million by 2025

Migraine Drugs Market is expected to reach $2,190 million with a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

sanketsolanki
Download Presentation

Migraine Drugs Market Expected to boost $2,190 Million by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Migraine Drugs Market Volume is expected to surpass $2,190 Million by 2025 Opportunity Analysis and IndustryForecast, 2016-2023 Global Opportunity Analysisand IndustryForecast, 2018-2025

  2. The global  Migraine Drugs Market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. Introduction • Migraine is a clinical condition associated with painful headaches and other symptoms such as nausea, sensitivity to smell, and others.  • Rise in prevalence of migraine drives the migraine drugs market.  • Increase in female population and surge in awareness among patients related to prevention and treatment of migraine are the key factors that augment the growth of the market. • Side effects associated with migraine drugs is a factor that hinders the market growth. On the contrary, the presence of growth opportunities in emerging nations is expected to provide new opportunities for the key players.

  3. Key Findings of theMarket • North America occupied two-fifths share of the global migraine drugs market. • Oral is anticipated to grow with the highest CAGR throughout the forecast period. • Europe is anticipated to occupy more than one-fourth market share of the global migraine drugs market by 2025. • Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

  4. Key Benefits • This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global migraine drugs market. • Migraine drugs market size and estimations are based on comprehensive analysis of the applications and developments in the industry. • A qualitative analysis based on innovative products and devices facilitate the strategic business planning. • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the migraine drugs industry. Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2811

  5. MarketSegmentation • By Type • Abortive Medicine • Triptans (Serotonin Receptor Agonists) • Ergotamine Derivative • Others • Preventive Medicine • Anticonvulsant • Antidepressant • Beta Blocker • Others • By Route of Administration • Oral • Injection • Others • By Distribution Channel • Hospital-based Pharmacies • Retail Pharmacies • Online Pharmacies

  6. Key Players of theMarket • Abbott Laboratories, • Allergan Plc., • AstraZeneca, • Eisai Co., Ltd., • Endo International Plc. • GlaxoSmithKline Plc. • Others For purchase enquiry, visit @https://www.alliedmarketresearch.com/purchase-enquiry/2811

  7. About Allied MarketResearch: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective marketdomain. ContactUs: 5933 NE Win Sivers Drive, #205, Portland, OR 97220, UnitedStates. Int'l: +1-503-894-6022 TollFree: +1-800-792-5285 Fax: +1-800-792-5285 Contact Allied MarketResearch

  8. ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/migraine-drugs-market Follow UsOn:

More Related